Molecular Genetics of Addiction and Related Heritable Phenotypes: Genome‐Wide Association Approaches Identify “Connectivity Constellation” and Drug Target Genes with Pleiotropic Effects
Year: 2008
Type: review
Abstract: Genome-wide association (GWA) can elucidate molecular genetic bases for human individual differences in complex phenotypes that include vulnerability to addiction. Here, we review (a) evidence that supports polygenic models with (at least) modest heterogeneity for the genetic architectures of addiction and several related phenotypes; (b) technical and ethical aspects of importance for understanding GWA data, including genotyping in individual samples versus DNA pools, analytic approaches, power estimation, and ethical issues in genotyping individuals with illegal behaviors; (c) the samples and the data that shape our current understanding of the molecular genetics of individual differences in vulnerability to substance dependence and related phenotypes; (d) overlaps between GWA data sets for dependence on different substances; and (e) overlaps between GWA data for addictions versus other heritable, brain-based phenotypes that include bipolar disorder, cognitive ability, frontal lobe brain volume, the ability to successfully quit smoking, neuroticism, and Alzheimer's disease. These convergent results identify potential targets for drugs that might modify addictions and play roles in these other phenotypes. They add to evidence that individual differences in the quality and quantity of brain connections make pleiotropic contributions to individual differences in vulnerability to addictions and to related brain disorders and phenotypes. A "connectivity constellation" of brain phenotypes and disorders appears to receive substantial pathogenic contributions from individual differences in a constellation of genes whose variants provide individual differences in the specification of brain connectivities during development and in adulthood. Heritable brain differences that underlie addiction vulnerability thus lie squarely in the midst of the repertoire of heritable brain differences that underlie vulnerability to other common brain disorders and phenotypes.
Authors: George R. Uhl, Tomas Drgon, Catherine Johnson, Chuan‐Yun Li, Carlo Contoreggi, Judith Hess, Daniel Naiman, Qing‐Rong Liu
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Awards: Understanding addiction vulnerability genes, Molecular Genetic Bases for Quit Success, COPING WITH DEPRESSION IN SMOKING CESSATION, G3559938614, THE SOCIAL PSYCHOLOGY OF GROUP PERCEPTION AND SMOKING, Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Humans, Psychobiological /Genetic Determinants-Smoking Cessation, Nicotine Dependence: Phenotype, Endophenotype & Contexts, MATCHING ANTIDEPRESSANT TREATMENT FOR SMOKING CESSATION, G657573766, CARDIOVASCULAR EFFECTS OF COCAINE IN CARDIOMYOPATHY, BIOBEHAVIORAL LUNG CANCER PREVENTION PROGRAM, G7673929271, Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Mice, CVD RISK FACTORS AND BRAIN MORPHOLOGY IN NHLBI TWINS, BRAIN AND TISSUE BANK FOR DEVELOPMENTAL DISORDERS, The genetics of weight, BMI, adiposity and obesity
OpenAlex ID: W2034053561
